Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma
Clinical trial NCT03331341 · COMPLETED
Trial details
- NCT number
- NCT03331341
- Sponsor
- University of Washington
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-09
- Primary completion
- 2023-12-21
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.